Primary cells obtained from CML patients exhibited increased expression of IRE1α and activated NLRP1 inflammasome, whereas inhibition of IRE1α or NLRP1 led to reduced proliferation and increased apoptosis of primary CML cells. The gene discussed is ERN1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.